Centre Hospitalier Universitaire Vaudois
Lausanne, Canton of Vaud, CH-1011, Switzerland
NCT Number: NCT01121003
8 healthy male volunteers will be studied each on 3 occasions, ie
* after 4 days on a weight maintenance diet containing 5% simple sugars + low physical activity * after 4 days on a weight maintenance diet containing 30% fructose + low physical activity * after 4 days on a weight maintenance diet containing 30% fructose + high physical activity At the end of each of these 3 periods, fructose induced hepatic de novo lipogenesis (13C palmitate synthesis in response to ingestion of a 13C fructose load) and plasma VLDL-triglyceride kinetics (measured with a bolus of 2H-labeled glycerol) will be measured
Looking for future studies?
Notify Me18 year–30 year
Male
Interventional
Not applicable
Lausanne, Canton of Vaud, CH-1011, Switzerland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: after 4 days on controlled diet+exercise
Measurement of 13C VLDL palmitate after ingestion of 13C fructose
Time frame: after 4 days on controlled diet+exercise
Modelling of 2H5-glycerol incorporation in VLDL afetr administration of a bolus of 2H5 glycerol
University of Lausanne
Other
Effects of a Weight Maintenance, High Fructose Diet and of Exercise on Hepatic Lipid Metabolism
Acronym: FRUCTEXER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05885750
Gut Microbiota, Inflammation
Turku, Finland
View Trial DetailsNCT07122765
Blood Flow Velocity, Carbohydrate Metabolism
Washington D.C., District of Columbia, United States
View Trial DetailsNCT06082726
Intestinal Absorption, Metabolism
Leuven, Belgium
View Trial DetailsNCT06686888
Glucose Homeostasis, Intestinal Absorption
Leuven, Belgium
View Trial Details